Awards & Advancement

EMD Serono names Hoyes president

Wednesday, July 20, 2011 11:33 AM

EMD Serono, an affiliate of Germany-based Merck, has named James Hoyes president. He will be responsible for driving the strategic direction of the U.S. commercial organization as well as managing the day-to-day business of the U.S. affiliate of Merck. Hoyes will also serve as a member of the executive management board for Merck Serono, the global pharmaceuticals division of Merck.

More... »


Debiopharm names management team

Wednesday, July 20, 2011 11:32 AM

Debiopharm Group, a Swiss-based global biopharmaceutical group of companies, has named a number of management figures to key positions.

More... »


CoLucid names Thomas P. Mathers CEO

Wednesday, July 20, 2011 11:28 AM

CoLucid Pharmaceuticals, a privately held biopharmaceutical company, has named Thomas P. Mathers its chief executive officer.

More... »

DVS Sciences raises $14.6 million

Friday, July 15, 2011 10:58 AM

The Ontario Institute for Cancer Research (OICR) and DVS Sciences have announced DVS Sciences has completed a $14.6 million series A financing. DVS, a Toronto-based spinoff from the University of Toronto, invented and manufactures instrumentation that enables paradigm-shifting biological research with potential clinical applications that include personalized medicine.

More... »

Vetter receives Frost & Sullivan award

Friday, July 15, 2011 10:50 AM

Vetter has received the Frost & Sullivan 2011 European Prefilled Injection Systems Customer Service Leadership Award. The international consulting company recognized Vetter for best practices in its collaboration with global customers; in particular, the quality of service the company creates for its partners. Vetter provides support from early development of drugs through regulatory approval and market supply worldwide.

More... »

Fuchs joins Provectus advisory board

Friday, July 15, 2011 10:48 AM

Provectus Pharmaceuticals, a development-stage oncology and dermatology biopharmaceutical company, has named Stuart Fuchs to its corporate advisory board. He is resigning from the board of directors.

More... »

Huron Consulting expands client base for Click Portal

Friday, July 15, 2011 10:45 AM

Huron Consulting Group, a provider of business consulting services, announced that the University of Calgary (U of C) has selected its Click Portal software to streamline and automate key research compliance processes.

More... »

Clinilabs selected for investigational medication study

Friday, July 15, 2011 10:43 AM

CRO Clinilabs has been selected to conduct a clinical research study on the effects of an investigational medication on the sleep of healthy volunteers.

More... »

Advanced Clinical names executive director

Friday, July 15, 2011 10:40 AM

Advanced Clinical, a provider of clinical research solutions, has named Eman Albazzaz Executive Director of Regulatory Affairs, to lead Advanced Clinical’s regulatory and pharmacovigilance efforts.

More... »

American Heart Association Great Rivers names president-elect

Friday, July 15, 2011 10:37 AM

Dr. William S. Weintraub, the John H. Ammon Chair of Cardiology and Director of Christiana Care Center for Outcomes Research, is now serving as president-elect of the American Heart Association Great Rivers affiliate board of directors.

More... »


CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs